DK1046395T3 - Plaster indeholdende heparin og diclofenac til topisk anvendelse - Google Patents

Plaster indeholdende heparin og diclofenac til topisk anvendelse

Info

Publication number
DK1046395T3
DK1046395T3 DK00107835T DK00107835T DK1046395T3 DK 1046395 T3 DK1046395 T3 DK 1046395T3 DK 00107835 T DK00107835 T DK 00107835T DK 00107835 T DK00107835 T DK 00107835T DK 1046395 T3 DK1046395 T3 DK 1046395T3
Authority
DK
Denmark
Prior art keywords
topical use
diclofenac
containing heparin
patches containing
heparin
Prior art date
Application number
DK00107835T
Other languages
English (en)
Inventor
Elisabetta Donati
Irina Rapaport
Original Assignee
Altergon Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altergon Sa filed Critical Altergon Sa
Application granted granted Critical
Publication of DK1046395T3 publication Critical patent/DK1046395T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00107835T 1999-04-21 2000-04-12 Plaster indeholdende heparin og diclofenac til topisk anvendelse DK1046395T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000834A IT1312088B1 (it) 1999-04-21 1999-04-21 Cerotto per uso topico contenente eparina e diclofenac.
EP00107835A EP1046395B1 (en) 1999-04-21 2000-04-12 Plaster for topical use containing heparin and diclofenac

Publications (1)

Publication Number Publication Date
DK1046395T3 true DK1046395T3 (da) 2005-10-03

Family

ID=11382783

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00107835T DK1046395T3 (da) 1999-04-21 2000-04-12 Plaster indeholdende heparin og diclofenac til topisk anvendelse

Country Status (9)

Country Link
US (3) US6592891B1 (da)
EP (1) EP1046395B1 (da)
AT (1) ATE297717T1 (da)
CA (1) CA2306214C (da)
DE (1) DE60020768T2 (da)
DK (1) DK1046395T3 (da)
ES (1) ES2244373T3 (da)
IT (1) IT1312088B1 (da)
PT (1) PT1046395E (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE310539T1 (de) 2001-12-21 2005-12-15 Coloplast As Artikel zur wundbehandlung
WO2004039358A1 (en) * 2002-10-30 2004-05-13 Showa Denko K.K. Adhesive composition for dermal patch and production process thereof
JP2004168764A (ja) * 2002-10-30 2004-06-17 Showa Denko Kk 貼付剤用粘着剤組成物およびその製造方法
EP1691746B1 (en) * 2003-12-08 2015-05-27 Gel-Del Technologies, Inc. Mucoadhesive drug delivery devices and methods of making and using thereof
EP1785131A4 (en) * 2004-08-31 2009-03-11 Aspion Co Ltd EXTERNAL PREPARATION OF TYPE S / O
WO2006112533A1 (en) * 2005-04-18 2006-10-26 Showa Denko K.K. Water-containing gel form and production method thereof
US20100323323A1 (en) * 2005-06-24 2010-12-23 Cao Group, Inc. Pliable gingival isolation material
US20090238763A1 (en) * 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
EP2756843A3 (en) 2006-07-25 2014-08-20 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of diclofenac with very fast skin penetration rate
BRPI0721709B1 (pt) 2007-06-04 2024-03-12 Techfields Inc. PRÓ-FÁRMACOS DE NSAIAs, PROCESSO PARA PREPARAÇÃO DOS MESMOS, SEU USO, SISTEMAS TERAPÊUTICOS DE APLICAÇÃO TRANSDÉRMICA E COMPOSIÇÃO QUE OS COMPREENDE
US7943668B2 (en) 2008-03-03 2011-05-17 Altergon S.A. Process for preparing a pharmaceutical composition with anti-inflammatory and analgesic activity for administration via a patch for external use, and composition thus obtained
WO2009109214A1 (en) * 2008-03-03 2009-09-11 Altergon S.A. Process for preparing a pharmaceutical composition with anti-inflammatory and analgesic activity for administration via a patch for external use, and composition thus obtained
CN104173321B (zh) * 2008-03-03 2017-10-31 阿尔特根有限公司 制备通过外用贴剂给药的、具有消炎镇痛活性的药物组合物的方法，及以此获得的组合物
TWI383802B (zh) 2008-12-04 2013-02-01 Chongxi Yu 高滲透性組合物及其應用
CN103357059B (zh) * 2012-03-27 2016-08-03 上海卫生材料厂有限公司 几丁质凝胶创可贴
US10905669B2 (en) 2015-02-20 2021-02-02 Altergon S.A. Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug
EP3173066A1 (en) * 2015-11-25 2017-05-31 Krzysztof Kubica Plaster comprising antiedematous substances for the treatment of bruising and injury

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855142A (en) * 1987-02-27 1989-08-08 Ciba-Geigy Corporation Pharmaceutical plaster
US4879282A (en) * 1987-03-17 1989-11-07 Saliba Jr Michael J Medical application for heparin and related molecules
US5041430A (en) * 1989-09-18 1991-08-20 Du Pont Mereck Pharmaceutical Company Oral anticoagulant/platelet inhibitor low dose formulation
US5217954A (en) * 1990-04-04 1993-06-08 Scios Nova Inc. Formulations for stabilizing fibroblast growth factor
JP2849937B2 (ja) * 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤
US5260066A (en) * 1992-01-16 1993-11-09 Srchem Incorporated Cryogel bandage containing therapeutic agent
IL101387A (en) * 1992-03-26 1999-11-30 Pharmos Ltd Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
JP3526887B2 (ja) * 1993-04-23 2004-05-17 帝國製薬株式会社 消炎鎮痛外用貼付剤
US5668119A (en) * 1996-02-22 1997-09-16 Medenica; Rajko D. Topical pharmaceutical containing heparin and method of treatment
AU2953497A (en) * 1996-05-13 1997-12-05 Novartis Consumer Health S.A. Topical composition
GB2320431B (en) * 1996-12-20 2000-08-30 Johnson & Johnson Medical Compositions for the treatment of chronic wounds

Also Published As

Publication number Publication date
EP1046395A1 (en) 2000-10-25
EP1046395B1 (en) 2005-06-15
ES2244373T3 (es) 2005-12-16
US20030203017A1 (en) 2003-10-30
PT1046395E (pt) 2005-10-31
CA2306214C (en) 2009-10-20
IT1312088B1 (it) 2002-04-04
CA2306214A1 (en) 2000-10-21
DE60020768D1 (de) 2005-07-21
US6592891B1 (en) 2003-07-15
ITMI990834A1 (it) 2000-10-21
ATE297717T1 (de) 2005-07-15
US7799338B2 (en) 2010-09-21
DE60020768T2 (de) 2006-05-18
US20050048101A1 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
DK1046395T3 (da) Plaster indeholdende heparin og diclofenac til topisk anvendelse
WO2007044647A3 (en) Pressure bandage with medication delivery system
ES2188907T3 (es) Dispositivo de soporte farmaceutico adecuado ppara la administracion de compuestos farmaceuticos a las superficies de las mucosas.
DK1009393T3 (da) Transdermalt, terapeutisk system med hæfteklæbende reservoirlag og bagsidelag, som er elastisk i én retning
WO2004103415A3 (en) Multi-dressing system for managing skin wounds
EE200200062A (et) Monoaminoksüdaasi inhibiitorite kasutamine ravimite valmistamiseks rasvumuse raviks
JP2005502430A5 (da)
DE602005016185D1 (de) Druckempfindliche Klebstoffzusammensetzung, druckempfindliches Klebeband und Oberflächenschutzfilm
MX2009005343A (es) Sistema terapeutico transdermico con alto grado de utilizacion de sustancia activa y precision de dosificacion.
TW570815B (en) Transdermal therapeutic system (TTS) containing the active substance fentanyl
DK1524975T3 (da) Forbedret, transdermalt tilförselssystem til indgivelse af rotigotin
EA201300704A1 (ru) Трансдермальная терапевтическая система для введения активного вещества
AU4451501A (en) Therapeutic anti-inflammatory and analgesic composition containing selective cox-2 inhibitor drugs for use transdermally and a process for the manufacture thereof
WO2005082428A3 (de) Pflaster mit reduzierter hautirritation
AU2003234936A1 (en) Liquid crystal aligning agent, liquid crystal aligning films and liquid crystal display devices
AU2003230032A1 (en) Transdermal delivery system with two superimposed adhesive layers having different affinities to the active substance comprised
CA2387143A1 (en) Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin
MX2009008993A (es) Dispositivo para la administracion percutanea de bisoprolol.
AU2003241564A1 (en) Thin film scar dressing and use thereof
EA201300648A1 (ru) Трансдермальная терапевтическая система (tts), содержащая ротиготин
ATE209912T1 (de) Transdermales therapeutisches system (tts) oxybutynin enthaltend
AU8197901A (en) Matrix controlled transdermal system for stabile derivatives of ace inhibitors
DK1034780T3 (da) Tyndt betametason- og hyaluronsyrebehandlet hæfteplaster til behandling af psoriasis, dermatitis og dermatose
AU2002210132A1 (en) Occlusive transdermal therapeutic system with a non-occlusive backing layer
NO20031211L (no) Plaster omfattende diclofenac